INNV Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio166.40Forward 13.66
EPS (TTM)$0.05-87.8% YoY
Profit margin0.7%HEALTHCARE
Market cap$1.13BSmall cap
Wall Street coverage
$7.00median target· current $4.32 (+62.0%)3 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 13.66
- PEG ratio
- 0.00
- P/B
- 4.40
- P/S (TTM)
- 1.23
- EV/EBITDA
- 37.17
Profitability & growth
- ROE (TTM)
- 1.2%
- Operating margin
- 5.5%
- Revenue growth YoY
- 14.7%
- Dividend yield
- —
- Beta
- 0.50
Last earnings
Feb 3, 2026 · Estimate $0.04 · Reported $0.08
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About InnovAge Holding Corp
Company profileInnovAge Holding Corp. The company is headquartered in Denver, Colorado.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 8950 E. LOWRY BOULEVARD, DENVER, CO
- Fiscal year end
- June
- Latest quarter
- Dec 31, 2025
Market cap$1.13B
Shares outstanding$135.7M
52W high$10.69
52W low$2.84
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
B
Agent
The AI built for clarity
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
B
Agent